Akèy › Skleroz Miltip › Pennsylvania
Etid klinik pou Skleroz Miltip nan Pennsylvania
7 etid pou Skleroz Miltip ap chèche patisipan nan sit nan Pennsylvania.
Vil nan Pennsylvania
Tèks ofisyèl etid la (Anglè)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Bethlehem
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06433752RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Pennsylvania, Philadelphia
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Thomas Jefferson University, Jefferson Headache Center, Philadelphia
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06782490Genes and Environment in Multiple Sclerosis
- University of Pittsburgh, Pittsburgh
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT01353547Central Vein Sign in Multiple Sclerosis Extension Study
- University of Pennsylvania, Philadelphia
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Feb 20, 2026 · NCT07424027Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
- University of Pittsburgh, Pittsburgh
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 7 ak plis · Tout sèks · Mizajou Dec 29, 2025 · NCT02994121Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.